Annual Operating Expenses
$83.53 M
+$44.74 M+115.33%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual total operating expenses is $83.53 million, with the most recent change of +$44.74 million (+115.33%) on December 31, 2023.
- During the last 3 years, ELVN annual operating expenses has risen by +$74.21 million (+796.43%).
- ELVN annual operating expenses is now at all-time high.
Performance
ELVN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$27.07 M
+$2.46 M+10.02%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly total operating expenses is $27.07 million, with the most recent change of +$2.46 million (+10.02%) on September 30, 2024.
- Over the past year, ELVN quarterly operating expenses has increased by +$1.08 million (+4.16%).
- ELVN quarterly operating expenses is now at all-time high.
Performance
ELVN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ELVN Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +115.3% | +4.2% |
| 3 y3 years | +796.4% | +64.9% |
| 5 y5 years | +796.4% | +64.9% |
ELVN Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +237.3% | at high | +222.4% |
| 5 y | 5-year | at high | +796.4% | at high | +222.4% |
| alltime | all time | at high | +796.4% | at high | +222.4% |
Enliven Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $27.07 M(+10.0%) |
| Jun 2024 | - | $24.60 M(-5.3%) |
| Mar 2024 | - | $25.99 M(+14.3%) |
| Dec 2023 | $83.53 M(+115.3%) | $22.73 M(-6.3%) |
| Sep 2023 | - | $24.25 M(+20.4%) |
| Jun 2023 | - | $20.13 M(+22.6%) |
| Mar 2023 | - | $16.42 M(+61.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $38.79 M(+56.7%) | $10.16 M(-7.1%) |
| Sep 2022 | - | $10.93 M(+21.3%) |
| Jun 2022 | - | $9.02 M(+3.9%) |
| Mar 2022 | - | $8.68 M(+3.4%) |
| Dec 2021 | $24.76 M(+165.7%) | - |
| Dec 2021 | - | $8.39 M |
| Dec 2020 | $9.32 M | - |
FAQ
- What is Enliven Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Enliven Therapeutics?
- What is Enliven Therapeutics annual operating expenses year-on-year change?
- What is Enliven Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly operating expenses year-on-year change?
What is Enliven Therapeutics annual total operating expenses?
The current annual operating expenses of ELVN is $83.53 M
What is the all time high annual operating expenses for Enliven Therapeutics?
Enliven Therapeutics all-time high annual total operating expenses is $83.53 M
What is Enliven Therapeutics annual operating expenses year-on-year change?
Over the past year, ELVN annual total operating expenses has changed by +$44.74 M (+115.33%)
What is Enliven Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ELVN is $27.07 M
What is the all time high quarterly operating expenses for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly total operating expenses is $27.07 M
What is Enliven Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ELVN quarterly total operating expenses has changed by +$1.08 M (+4.16%)